相似文献
1
N9-substituted 2,4-diaminoquinazolines: synthesis and biological evaluation of lipophilic inhibitors of pneumocystis carinii and toxoplasma gondii dihydrofolate reductase.
J Med Chem. 2008 Oct 9;51(19):6195-200. doi: 10.1021/jm800694g. Epub 2008 Sep 5.
2
6-Substituted 2,4-diaminopyrido[3,2-d]pyrimidine analogues of piritrexim as inhibitors of dihydrofolate reductase from rat liver, Pneumocystis carinii, and Toxoplasma gondii and as antitumor agents.
J Med Chem. 1998 Nov 5;41(23):4533-41. doi: 10.1021/jm980206z.
3
2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases.
J Med Chem. 1996 Mar 29;39(7):1438-46. doi: 10.1021/jm950786p.
4
Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.
J Med Chem. 1998 Aug 27;41(18):3426-34. doi: 10.1021/jm980081y.
5
Effect of N9-methylation and bridge atom variation on the activity of 5-substituted 2,4-diaminopyrrolo[2,3-d]pyrimidines against dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.
J Med Chem. 1997 Mar 28;40(7):1173-7. doi: 10.1021/jm960717q.
6
Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents.
J Med Chem. 2003 Nov 6;46(23):5074-82. doi: 10.1021/jm030312n.
7
Nonclassical 2,4-diamino-8-deazafolate analogues as inhibitors of dihydrofolate reductases from rat liver, Pneumocystis carinii, and Toxoplasma gondii.
J Med Chem. 1996 Apr 26;39(9):1836-45. doi: 10.1021/jm950918e.
8
Structure-activity and structure-selectivity studies on diaminoquinazolines and other inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
Antimicrob Agents Chemother. 1995 Jan;39(1):79-86. doi: 10.1128/AAC.39.1.79.
9
Selective Pneumocystis carinii dihydrofolate reductase inhibitors: design, synthesis, and biological evaluation of new 2,4-diamino-5-substituted-furo[2,3-d]pyrimidines.
J Med Chem. 1998 Apr 9;41(8):1263-71. doi: 10.1021/jm970537w.
10
Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines.
J Med Chem. 1999 Jul 1;42(13):2447-55. doi: 10.1021/jm990079m.
引用本文的文献
1
Medicinal chemistry perspective of pyrido[2,3-]pyrimidines as anticancer agents.
RSC Adv. 2023 Feb 28;13(10):6872-6908. doi: 10.1039/d3ra00056g. eCollection 2023 Feb 21.
2
Review on the Synthesis and Therapeutic Potential of Pyrido[2,3-], [3,2-], [3,4-] and [4,3-]pyrimidine Derivatives.
Pharmaceuticals (Basel). 2022 Mar 14;15(3):352. doi: 10.3390/ph15030352.
3
Chemical space of Escherichia coli dihydrofolate reductase inhibitors: New approaches for discovering novel drugs for old bugs.
Med Res Rev. 2019 Mar;39(2):684-705. doi: 10.1002/med.21538. Epub 2018 Sep 7.
4
Quionolone carboxylic acid derivatives as HIV-1 integrase inhibitors: Docking-based HQSAR and topomer CoMFA analyses.
J Chemom. 2017 Dec;31(12). doi: 10.1002/cem.2934. Epub 2017 Aug 29.
5
Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7017-7034. doi: 10.1128/AAC.01176-16. Print 2016 Dec.
6
Design, synthesis, and molecular modeling of novel pyrido[2,3-d]pyrimidine analogues as antifolates; application of Buchwald-Hartwig aminations of heterocycles.
J Med Chem. 2013 Jun 13;56(11):4422-41. doi: 10.1021/jm400086g. Epub 2013 May 21.
7
CoMFA/CoMSIA 3D-QSAR of pyrimidine inhibitors of Pneumocystis carinii dihydrofolate reductase.
J Mol Model. 2012 Sep;18(9):4061-72. doi: 10.1007/s00894-012-1399-y. Epub 2012 Apr 14.
8
Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii.
J Med Chem. 2010 May 13;53(9):3594-601. doi: 10.1021/jm901857d.
本文引用的文献
1
Analysis of quinazoline and pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolates in complex with NADP+ and Pneumocystis carinii dihydrofolate reductase.
Acta Crystallogr D Biol Crystallogr. 2002 Sep;58(Pt 9):1393-9. doi: 10.1107/S0907444902010442. Epub 2002 Aug 23.
2
The relationship of preventable opportunistic infections, HIV-1 RNA, and CD4 Cell counts to chronic mortality.
J Acquir Immune Defic Syndr. 2002 Aug 1;30(4):421-8. doi: 10.1097/00042560-200208010-00008.
3
Synthesis of N-[4-[1-ethyl-2-(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid as an antifolate.
J Med Chem. 2002 Apr 25;45(9):1942-8. doi: 10.1021/jm010575m.
4
Synthesis of 2,4-diamino-6-(thioarylmethyl)pyrido[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.
Bioorg Med Chem. 2001 Nov;9(11):2929-35. doi: 10.1016/s0968-0896(01)00223-1.
5
Design, synthesis, and X-ray crystal structure of a potent dual inhibitor of thymidylate synthase and dihydrofolate reductase as an antitumor agent.
J Med Chem. 2000 Oct 19;43(21):3837-51. doi: 10.1021/jm000200l.
6
Effect of C9-methyl substitution and C8-C9 conformational restriction on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines.
J Med Chem. 2000 Aug 10;43(16):3125-33. doi: 10.1021/jm000130i.
7
Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines.
J Med Chem. 1999 Jul 1;42(13):2447-55. doi: 10.1021/jm990079m.
8
Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
J Med Chem. 1999 Mar 25;42(6):1007-17. doi: 10.1021/jm980572i.
9
6-Substituted 2,4-diaminopyrido[3,2-d]pyrimidine analogues of piritrexim as inhibitors of dihydrofolate reductase from rat liver, Pneumocystis carinii, and Toxoplasma gondii and as antitumor agents.
J Med Chem. 1998 Nov 5;41(23):4533-41. doi: 10.1021/jm980206z.
10
Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.
J Med Chem. 1998 Aug 27;41(18):3426-34. doi: 10.1021/jm980081y.
Zotero 插件